INTRODUCTION
Systemic sclerosis is a rare, autoimmune, progressive disease that affects
connective tissues and internal organs by inflammation, fibrosis, or
vasculopathies1. It is more common in
women (4:1), and its onset occurs between the ages of 30 and 50 years1. Calcinosis cutis is frequently found in
systemic sclerosis, but its spectrum of presentations is reported
anecdotally2.
When present, calcinosis can progress to painful, disabling conditions and may
become infected, especially with skin ulcerations, requiring a surgical
treatment approach3. As of now, calcinosis
related to systemic sclerosis has received little attention in studies,
including its pathogenesis and related diseases3. While surgical treatments for calcinosis cutis in hands and
fingers have been reported, we found few studies about calcinosis cutis in other
areas, such as the present case of calcinosis cutis in the inguinal region4.
CASE REPORT
A 53-year-old female patient was referred to and treated in the rheumatology
department of the University Hospital of the Federal University of Santa
Catarina (HU/UFSC) in Florianópolis, Santa Catarina. She was diagnosed as having
systemic sclerosis 20 years before and presented with calcinosis in the
bilateral inguinal region, which was suggestive of dystrophic calcinosis.
A surgical procedure to remove the calcium lesions was requested because of
continuous moderate/severe pain without precipitating and relieving factors, and
the risks of ulceration and infection from the progressive characteristic of the
localized disease.
Clinical treatment with medication was given but failed to stop the progression
of the calcinosis or attain remission. The patient took azathioprine and
prednisone to stabilize the underlying disease and denied prior surgeries. In
the physical examination, she presented with a hardened cluster of lesions
adhered to the subcutaneous tissue in the inguinal region and bilateral flanks
that were compatible with calcinosis and felt discomfort with light, passive
movements. She showed no signs of localized infection or ulceration. The lesions
covered an area of 20 × 5 cm (Figure 1). Ultrasonography of the inguinal region showed hyperechoic linear
and irregular masses projecting from the subcutaneous tissue in the inferior
area of the lateral abdominal wall, the largest ones being 36 mm in length,
which were compatible with calcification.
Figure 1 - Anteroposterior and oblique radiograph of the inguinal region
presenting with calcinosis cutis in the direct inguinal region,
flanks, and perianal region.
Figure 1 - Anteroposterior and oblique radiograph of the inguinal region
presenting with calcinosis cutis in the direct inguinal region,
flanks, and perianal region.
Concerning the progressive state of the localized disease, the unsuccessful
attempt at clinical drug treatment, and the patient’s considerable pain,
surgical resection was indicated.
We marked the inguinal region, contemplating the entire affected area through
palpation in the physical and imaging examination (a cutaneous site marking of
approximately 15 × 4 cm). Local anesthesia was administered with 50 mL of
solution containing 20 mL of 2% lidocaine, 1/120,000 adrenaline, and 100 mL of
saline. We performed cutaneous and subcutaneous resections to remove the
calcinosis, which had formed clusters of calcium lesions, some of which had
adhered to the fascia of the external oblique muscle, without resection of the
fascia or external oblique muscle.
We removed a single block containing cutaneous and subcutaneous tissues affected
by the calcinosis. After hemostasis, we used simple nylon 2.0 sutures in the
subdermal plane for primary closure and continuous 3.0 nylon sutures in the
intradermal plane for aesthetic closure and minor inflammatory reaction (Figure 2).
Figure 2 - Counterclockwise. A: Preoperative marking (15
× 4 cm) of the inguinal region. B: Resection of
the calcinosis in a single cutaneous and subcutaneous block,
maintaining the fascia of the oblique external muscle.
C: Closure by planes with intradermal
sutures.
Figure 2 - Counterclockwise. A: Preoperative marking (15
× 4 cm) of the inguinal region. B: Resection of
the calcinosis in a single cutaneous and subcutaneous block,
maintaining the fascia of the oblique external muscle.
C: Closure by planes with intradermal
sutures.
The site was dressed with neomycin and mild cutaneous compression, and the
dressing was to be changed daily after a bath. The patient adhered to the
postoperative follow-up care, and the intradermal sutures were removed on the
12th day. At this time, the patient no longer presented with
localized daily pain caused by calcinosis; thereby, a subjective analysis of the
patient’s pain (preoperative and postoperative) was conducted.
In the second postoperative month, the patient’s condition progressed with the
extrusion of a subdermal suture without the need for secondary surgery and
without a surgical wound, other intercurrences, or complications.
The photographs show a favorable aesthetic result on the 90th
postoperative day (Figure 3). The
histological evaluation demonstrated no degree of malignancy in the
calcifications (Figure 4). The patient is
currently under follow-up care by the plastic surgery department of HU/UFSC and
did not present with new calcifications in the surgical area or atrophic scars
during recovery.
Figure 3 - A and B: Preoperative images of the
inguinal region (anterior profile). C and
D: Postoperative images after 3 months of recovery,
showing topical and trophic healing. The extrusion site of the
subdermal suture in the healing process by secondary intention is
shown.
Figure 3 - A and B: Preoperative images of the
inguinal region (anterior profile). C and
D: Postoperative images after 3 months of recovery,
showing topical and trophic healing. The extrusion site of the
subdermal suture in the healing process by secondary intention is
shown.
Figure 4 - Calcification in the hypodermis (hematoxylin-eosin staining,
original magnification ×100).
Figure 4 - Calcification in the hypodermis (hematoxylin-eosin staining,
original magnification ×100).
DISCUSSION
Systemic sclerosis is a disabling disease that involves the interdisciplinary
participation of physicians, as it indiscriminately affects all body systems.
The rheumatologist is in charge of clinical follow-up, as it is a connective
tissue disorder. However, the collaboration of other specialties sometimes
becomes unquestionable5.
Calcification of soft tissue is generally categorized into four types, namely
dystrophic calcification, metastatic calcification, idiopathic calcification,
and calciphylaxis. In dystrophic calcification, serum calcium and phosphate
levels are normal. This is commonly related to connective tissue diseases such
as dermatomyositis and scleroderma5.
Calcinosis caused by systemic sclerosis is a condition in which the last
treatment option is surgical resection because of the uncertainty of recovery
from surgical trauma before the underlying disease. Drug treatment, which has
not been standardized, seeks to contain the progression of calcinosis in terms
of size and cutaneous ulceration. Drug intervention has provided mixed results
in its effectiveness, and its results vary according to studies.
Calcium channel blockers have demonstrated the greatest efficacy among other drug
interventions. They promote a decrease in the influx of calcium into the cell,
thereby decreasing the formation of intracellular crystals. While colchicine
does not affect the calcium lesions themselves, it reduces secondary
inflammation6-9.
As in this case, some patients present moderate to severe pain due to the
clusters of sensitive cutaneous innervations, which accelerate the search for
their surgical treatments. Nonetheless, little information is available in the
surgical literature on calcinosis in patients with connective tissue disease,
particularly in the inguinal region, which is an unusual topography of the
disease, as it normally occurs in the extremities and joints6,7.
Although risks of pain recurrence and additional calcification due to surgical
trauma are present, treatment of calcinosis before it progresses to localized
ulceration and infection is favorable7.
This case report serves as a reference for future research. The best treatment
for calcinosis cutis is still unclear, as no fully effective treatment is
available. We attempted clinical drug treatment to stop or slow disease
progression. Surgical treatment is the last option because of uncertainties
about recovery from surgical trauma2.
Consequently, treating complications becomes essential to reducing the patients’
morbidity and increasing their quality of life. In cases with an imprecise
postoperative recovery, the physician-patient relationship should guide
procedures to prevent future discontent of treatment outcomes.
COLLABORATIONS
CPG
|
Conception and design study, methodology, project administration,
writing - original draft preparation.
|
NBR
|
Data curation, writing - original draft preparation.
|
CMM
|
Data curation, writing - original draft preparation.
|
FCNG
|
Data curation.
|
JBE
|
Conceptualization, supervision, writing - review & editing.
|
REFERENCES
1. Jecan CR, Bedereag SI, Sinescu RD, Grigorean VT, Cozma CN, Bordianu
A, et al. A case of a generalized symptomatic calcinosis in systemic sclerosis.
Rom J Morphol Embryol. 2016;57(2 Suppl):865-9.
2. Vayssairat M, Hidouche D, Abdoucheli-Baudot N, Gaitz JP. Clinical
significance of subcutaneous calcinosis in patients with systemic sclerosis.
Does diltiazem induce its regression? Ann Rheum Dis. 1998;57(4):252-4. PMID:
9709184 DOI: http://dx.doi.org/10.1136/ard.57.4.252
3. Mahmood M, Wilkinson J, Manning J, Herrick AL. History of surgical
debridement, anticentromere antibody, and disease duration are associated with
calcinosis in patients with systemic sclerosis. Scand J Rheumatol.
2016;45(2):114-7. DOI: http://dx.doi.org/10.3109/03009742.2015.1086432
4. Selig HF, Pillukat T, Mühldorfer-Fodor M, Schmitt S, van Schoonhoven
J. Surgical treatment of extensive subcutaneous calcification of the forearm in
CREST syndrome. J Plast Reconstr Aesthet Surg. 2013;66(12):1817-8. DOI:
http://dx.doi.org/10.1016/j.bjps.2013.06.035
5. Radu F, Nishiaoki M, Louis MA. Calcinosis Cutis and Negative
Pressure Wound Therapy as Adjuncts to Surgical Management: Case Report and
Review of the Literature. Wounds. 2018;30(3):E32-5.
6. Saddic N, Miller JJ, Miller OF 3rd, Clarke JT. Surgical debridement
of painful fingertip calcinosis cutis in CREST syndrome. Arch Dermatol.
2009;145(2):212-3. PMID: 19221282 DOI: http://dx.doi.org/10.1001/archderm.145.2.212-b
7. Mendelson BC, Linscheid RL, Dobyns JH, Muller SA. Surgical treatment
of calcinosis cutis in the upper extremity. J Hand Surg Am. 1977;2(4):318-24.
DOI: http://dx.doi.org/10.1016/S0363-5023(77)80136-6
8. Robertson LP, Marshall RW, Hickling P. Treatment of cutaneous
calcinosis in limited systemic sclerosis with minocycline. Ann Rheum Dis.
2003;62(3):267-9. PMID: 12594118 DOI: http://dx.doi.org/10.1136/ard.62.3.267
9. Harigane K, Mochida Y, Ishii K, Ono S, Mitsugi N, Saito T.
Dystrophic calcinosis in a patient with rheumatoid arthritis. Mod Rheumatol.
2011;21(1):85-8. DOI: http://dx.doi.org/10.3109/s10165-010-0344-0
1. Hospital Universitário, Universidade Federal de
Santa Catarina, Florianópolis, SC, Brazil.
Corresponding author: Caio Pundek
Garcia Madre Benvenuta, nº 322 - Trindade, Florianópolis, SC, Brazil
Zip Code 88036-595 E-mail: caio_pgarcia@hotmail.com /
caio@polski.com.br
Article received: March 23, 2018.
Article accepted: November 11, 2018.
Conflicts of interest: none.